India to Mexico: Bortezomib Export Trade Route

The India to Mexico Bortezomib corridor is one of India's established pharmaceutical export routes, with 45 shipments documented worth a combined $698.6K USD. The route is dominated by GLENMARK PHARMACEUTICALS LIMITED, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's bortezomib manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $15.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with bortezomib's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 13.7%, placing it at rank #9 among India's top bortezomib export destinations globally.

On the import side, key buyers of Indian bortezomib in Mexico include GLENMARK PHARMACEUTICALS MEXICO, AYUSH PHARMA S.A DE C.V , AYUSH PHARMA SA and 12 others. GLENMARK PHARMACEUTICALS MEXICO is the single largest importer with 2 shipments valued at $377.2K USD.

India's bortezomib exports to Mexico are driven primarily by a handful of large-scale manufacturers. GLENMARK PHARMACEUTICALS LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Mexico benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLENMARK PHARMACEUTICALS LIMITED, SP ACCURE LABS PRIVATE LIMITED , SP ACCURE LABS PVT LTD — together account for 87% of total trade value on this route. The average shipment value of $15.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as exfucikanet (bortezomib) inj 3.5mg3143vls60.85 and bowie (bortezomib powder for solution fo , suggesting that buyers in Mexico tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, GLENMARK PHARMACEUTICALS MEXICO is the largest importer with 2 shipments worth $377.2K USD — representing 54% of all bortezomib imports from India on this route. A total of 15 buyers are active on this corridor.